Nucleotide substitution: C?T.
Amino acid replacement: P91L.
There is a missense mutation in the GPHR coding region that substitutes a highly conserved Proline to a Leucine in the third transmembrane domain of the protein.
C15200698T
C?T
P91L | GPHR-PA
P91L
GPHRk34 larval escapers survive through the pupal stage to give rise to pharate adults that are significantly smaller and lighter than control animals. While GPHRk34 mutant and wild-type larvae grow equally until late mid-L3 stage (96 hr after egg deposition), GPHRk34 mutant larvae show growth deceleration at late L3. By late L3 and pupal stages, size differences between wild-type and mutant siblings are obvious. In addition, the onset of both pupariation and adult emergence are delayed in GPHRk34 mutants.
Both cell size and number are reduced in GPHRk34 homozygous and GPHRk34/Df(2R)ED2426 mutant adult wing blades.
GPHRk34 homozygous mutant mitotic wing imaginal disc clones grow and divide to clones of a similar size as wild-type clones. These cells do not show differences in cell division or size, compared to controls. Although GPHRk34 mutant larvae (120 hrs after egg deposition) display salivary gland cells with reduced nuclei size when compared to controls, no obvious differences in nuclei size are observed between GPHRk34 mutant MARCM salivary gland cell clones and wild-type cells.
GPHRk34 mutants exhibit severe endoplasmic reticulum and Golgi disorganisation.
GPHRk34 has decreased body size phenotype, suppressible by Hsap\GPR89AUAS.cCa/Scer\GAL4da.G32
GPHRk34 has decreased cell size phenotype, suppressible by Hsap\GPR89AUAS.cCa/Scer\GAL4da.G32
GPHRk34 has decreased cell number phenotype, suppressible by Hsap\GPR89AUAS.cCa/Scer\GAL4da.G32
GPHRk34 has decreased body size phenotype, suppressible by Cgri\GphrUAS.cCa/Scer\GAL4da.G32
GPHRk34 has decreased cell size phenotype, suppressible by Cgri\GphrUAS.cCa/Scer\GAL4da.G32
GPHRk34 has decreased cell number phenotype, suppressible by Cgri\GphrUAS.cCa/Scer\GAL4da.G32
Ubiquitous expression of Hsap\GPR89AScer\UAS.cCa under the control of Scer\GAL4da.G32 is sufficient to fully suppress the growth defects and developmental lethality seen in GPHRk34 mutants.
Ubiquitous expression of Zzzz\GphrScer\UAS.cCa under the control of Scer\GAL4da.G32 is sufficient to fully suppress the growth defects and developmental lethality seen in GPHRk34 mutants.
GPHRk34 is rescued by Scer\GAL4da.G32/GPHRUAS.cCa
GPHRk34 is rescued by Scer\GAL4elav-C155/GPHRUAS.cCa
GPHRk34 is rescued by Scer\GAL4c601/GPHRUAS.cCa
GPHRk34 is not rescued by Scer\GAL4Mef2.PR/GPHRUAS.cCa
Ubiquitous, neuronal or gut expression of GPHRScer\UAS.T:Ivir\HA1 under the control of Scer\GAL4da.G32 is sufficient to fully rescue the growth defects and developmental lethality seen in GPHRk34 mutants. Muscle expression (under the control of Scer\GAL4Mef2.PR does not rescue.